KORE has announced its acquisition of Business Mobility Partners (BMP), a mobility solution provider focused on delivering IoT enablement services to contract research organizations (CROs) and remote patient monitoring (RPM) customers.
Together, these two companies can provide a solidified front for remote clinical trials, allowing the configuration of software and physical production of remote patient monitoring kits. The acquisition will accelerate the adoption of remote clinical trials around the world.
Read more about the acquisition here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.